Alternatives to Moderna

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Advancing next-generation mRNA medicines.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Biopharmaceutical company developing innovative therapies for sepsis and intensive care.

Developing disease-responsive advanced therapies through programmable gene control technology.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Therapeutics company developing novel treatments for complex diseases.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Developing novel RNA-targeting compounds for cancer and rare genetic diseases.

Vaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A global leader in clinical pharmacology and bioanalytical sciences.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Pioneering vision restoration therapies for severe retinal degenerations.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.